Abstract
Percutaneous thrombectomy has become an established treatment for thrombosed hemodialysis access. Thrombuster IITM, which removes the clot by aspiration, is a new device for percutaneous transluminal thrombectomy. Thrombectomy using Thrombuster IITM does not need either urokinase or the complicated machinery because of its simple structure. Our study evaluated the usefulness of this device for removing the thrombi from the thrombosed hemodialysis access and determined the clinical success rate. Thrombectomy was performed in 20 thrombosed hemodialysis access routes by using this device. The clinical successful rate of this method was 85.0%; the success rate for grafts was 85.7% and that for native vascular access was 83.3%. The volume of bleeding was 100mL or less in all patients except one (130mL). We concluded that percutaneous transluminal thrombectomy by using Thrombuster IITM was effective and useful.
